Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells-Reference-Cited by-同舟云学术

Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells

Published:2020-09 Issue: Volume:210 Page:111155
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Pavlović Marijana,Tadić Ana,Gligorijević Nevenka,Poljarević Jelena,Petrović Tamara,Dojčinović Biljana,Savić Aleksandar,Radulović Siniša,Grgurić-Šipka Sanja,Aranđelović Sandra

Funder

Ministry of Education, Science and Technological Development of the Republic of Serbia

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference104 articles.

1. Toxic effects of cis-dichlorodiammineplatinum(II) in man;Von Hoff;Cancer Treat. Rep.,1979

2. Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation;Astolfi;Oncol. Rep.,2013

3. The side effects of platinum-based chemotherapy drugs: a review for chemists;Oun;Dalton Trans.,2018

4. Metal-based antitumor compounds: beyond cisplatin;Simpson;Future Med. Chem.,2019

5. The potential of organometallic complexes in medicinal chemistry;Gasser;Curr. Opin. Chem. Biol.,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024

2. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor;Journal of Medicinal Chemistry;2023-10-03

3. Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs;Molecules;2023-05-08

4. Triumphs and challenges in exploiting poly(ADP‐ribose) polymerase inhibition to combat triple‐negative breast cancer;Journal of Cellular Physiology;2023-04-12

5. Exploring heterometallic bridged Pt(II)-Zn(II) complexes as potential antitumor agents;Journal of Inorganic Biochemistry;2023-03